Literature DB >> 2390922

Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.

J B Jansen1, A J de Jong, M V Singer, W Niebel, L C Rovati, C B Lamers.   

Abstract

This study was undertaken to delineate the role of cholecystokinin (CCK) in bombesin- and meal-stimulated pancreatic polypeptide (PP) secretion in seven conscious dogs by studying: (1) the stimulatory effect of similar plasma levels of CCK induced by a meal and infusions of bombesin and the synthetic CCK analog cerulein on plasma PP, and (2) the inhibition of PP secretion by the CCK-receptor antagonist CR-1409 during these three stimuli. The stimulation of PP secretion during bombesin (11.0 +/- 1.6 nM/hr) and after the meal (8.9 +/- 2.0 nM/hr) were significantly (P less than 0.05) greater than during infusion of the CCK analog cerulein (2.7 +/- 0.4 nM/hr). CR-1409 significantly inhibited the bombesin- and meal-stimulated PP secretion to 2.0 +/- 0.4 nM/hr (81%; P less than 0.05) and 3.1 +/- 1.2 nM/hr (47%; P less than 0.05), respectively, while the cerulein-stimulated PP release was almost abolished to 0.2 +/- 0.1 nM/hr (93%; P less than 0.05) by the drug. These findings point to an important role for CCK in the regulation of bombesin- and meal-stimulated PP secretion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390922     DOI: 10.1007/bf01537577

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  A newly recognized pancreatic polypeptide; plasma levels in health and disease.

Authors:  J C Floyd; S S Fajans; S Pek; R E Chance
Journal:  Recent Prog Horm Res       Date:  1976

2.  Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.

Authors:  S J Konturek; J Tasler; M Cieszkowski; K Szewczyk; M Hladij
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

3.  Release of pancreatic polypeptide in humans by infusion of cholecystokinin.

Authors:  J Lonovics; S Guzman; P Devitt; K E Hejtmancik; R L Suddith; P L Rayford; J C Thompson
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

4.  Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry.

Authors:  L I Larsson; F Sundler; R Håkanson
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

5.  CCK receptors in release of pancreatic polypeptide (PP) in dogs.

Authors:  S J Konturek; P Konturek; W Bielański; K Szewczyk
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

6.  Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs.

Authors:  S J Konturek; J Tasler; J W Konturek; M Cieszkowski; K Szewczyk; M Hładij; P S Anderson
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

7.  Immunoreactive GRP.

Authors:  N Yanaihara; C Yanaihara; T Mochizuki; K Iwahara; T Fujita; T Iwanaga
Journal:  Peptides       Date:  1981       Impact factor: 3.750

8.  Effect of pancreatic polypeptide-antiserum on bombesin-stimulated pancreatic exocrine secretion in dogs.

Authors:  A J de Jong; M V Singer; C B Lamers
Journal:  Peptides       Date:  1987 Nov-Dec       Impact factor: 3.750

9.  Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.

Authors:  P Hildebrand; C Beglinger; E Köhler; I Setnikar; K Gyr
Journal:  Regul Pept       Date:  1987-08-17

10.  Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.

Authors:  T E Solomon; T Yamada; J Elashoff; J Wood; C Beglinger
Journal:  Am J Physiol       Date:  1984-07
View more
  1 in total

1.  Pulmonary Neuroendocrine Cells and Lung Development.

Authors:  Mary E. Sunday
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.